Rockwell Medical, Inc. - stock earnings
RMTI Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q3 | -1.9 million USD | 23.8 million USD |
2023Q2 | -3.3 million USD | 18.1 million USD |
2023Q1 | -2.5 million USD | 19.7 million USD |
2022Q4 | -2.8 million USD | 19.3 million USD |
2022Q3 | -4.7 million USD | 18.7 million USD |
2022Q2 | -5.5 million USD | 18.7 million USD |
2022Q1 | -8.9 million USD | 15.3 million USD |
2021Q4 | -8.9 million USD | 15.3 million USD |
2021Q3 | -7.6 million USD | 16.0 million USD |
2021Q2 | -8.4 million USD | 15.1 million USD |
2021Q1 | -7.8 million USD | 15.5 million USD |
2020Q4 | -8.7 million USD | 15.2 million USD |
2020Q3 | -7.4 million USD | 15.3 million USD |
2020Q2 | -6.9 million USD | 15.9 million USD |
2020Q1 | -8.0 million USD | 15.9 million USD |
2019Q4 | -7.3 million USD | 15.5 million USD |
2019Q3 | -7.9 million USD | 15.4 million USD |
2019Q2 | -10.3 million USD | 14.8 million USD |
2019Q1 | -8.7 million USD | 15.6 million USD |
2018Q4 | -9.4 million USD | 16.9 million USD |
2018Q3 | -5.0 million USD | 16.7 million USD |
2018Q2 | -12.2 million USD | 14.9 million USD |
2018Q1 | -6.5 million USD | 14.9 million USD |
2017Q4 | -9.0 million USD | 14.8 million USD |
2017Q3 | -5.1 million USD | 14.6 million USD |
2017Q2 | -7.1 million USD | 13.2 million USD |
2017Q1 | -4.7 million USD | 14.6 million USD |
2016Q4 | -5.1 million USD | 13.4 million USD |
2016Q3 | -4.6 million USD | 12.8 million USD |
2016Q2 | -5.4 million USD | 13.5 million USD |
2016Q1 | -4.8 million USD | 13.6 million USD |
2015Q4 | -5.8 million USD | 14.1 million USD |
2015Q3 | -2.4 million USD | 14.4 million USD |
2015Q2 | -2.5 million USD | 13.0 million USD |
2015Q1 | -3.7 million USD | 13.9 million USD |
2014Q4 | -6.4 million USD | 14.4 million USD |
2014Q3 | -4.0 million USD | 13.7 million USD |
2014Q2 | -3.2 million USD | 13.0 million USD |
2014Q1 | -7.8 million USD | 13.0 million USD |
2013Q4 | -8.3 million USD | 14.0 million USD |
2013Q3 | -13.2 million USD | 13.1 million USD |
2013Q2 | -11.9 million USD | 13.0 million USD |
2013Q1 | -15.4 million USD | 12.3 million USD |
2012Q4 | -13.7 million USD | 13.0 million USD |
2012Q3 | -17.9 million USD | 12.7 million USD |
2012Q2 | -11.9 million USD | 12.1 million USD |
2012Q1 | -10.6 million USD | 12.0 million USD |
2011Q4 | -9.0 million USD | 11.9 million USD |
2011Q3 | -5.0 million USD | 12.0 million USD |
2011Q2 | -4.5 million USD | 11.8 million USD |
2011Q1 | -2.9 million USD | 13.3 million USD |
2010Q4 | -1.7 million USD | 14.3 million USD |
2010Q3 | -743357 USD | 14.7 million USD |
2010Q2 | 116917 USD | 15.5 million USD |
2010Q1 | -393680 USD | 15.0 million USD |
2009Q4 | -549781 USD | 14.8 million USD |
2009Q3 | -1.5 million USD | 14.2 million USD |
2009Q2 | -1.7 million USD | 13.0 million USD |
2009Q1 | -1.7 million USD | 12.8 million USD |
2008Q4 | -3.0 million USD | 13.5 million USD |
2008Q3 | -2.5 million USD | 13.5 million USD |
2008Q2 | -1.1 million USD | 12.2 million USD |
2008Q1 | -1.2 million USD | 12.4 million USD |
2007Q4 | -1.2 million USD | 11.9 million USD |
2007Q3 | -432912 USD | 11.1 million USD |
2007Q2 | -476625 USD | 10.5 million USD |
2007Q1 | -1.6 million USD | 9.5 million USD |
2006Q4 | -1.2 million USD | 9.2 million USD |
2006Q3 | -1.6 million USD | 7.4 million USD |
2006Q2 | -1.5 million USD | 5.9 million USD |
2006Q1 | -289218 USD | 6.2 million USD |
2005Q4 | -274040 USD | 6.5 million USD |
2005Q3 | 156177 USD | 7.8 million USD |
2005Q2 | 85456 USD | 7.8 million USD |
2005Q1 | 109215 USD | 5.6 million USD |
2004Q4 | 11404 USD | 4.8 million USD |
2004Q3 | 65277 USD | 4.5 million USD |
2004Q2 | 54625 USD | 4.4 million USD |
2004Q1 | 80217 USD | 4.3 million USD |
2003Q4 | 100025 USD | 4.1 million USD |
2003Q3 | 84850 USD | 3.9 million USD |
2003Q2 | -93230 USD | 3.5 million USD |
2003Q1 | -86793 USD | 3.4 million USD |
2002Q4 | -72847 USD | 3.6 million USD |
2002Q3 | -182852 USD | 2.9 million USD |
2002Q2 | -378798 USD | 2.6 million USD |
2002Q1 | -477826 USD | 2.3 million USD |
2001Q4 | -477826 USD | 2.3 million USD |
2001Q3 | -459844 USD | 2.3 million USD |
2001Q2 | -355747 USD | 2.2 million USD |
2001Q1 | -120003 USD | 2.1 million USD |
2000Q4 | -120003 USD | 2.1 million USD |
2000Q3 | -307086 USD | 2.0 million USD |
2000Q2 | -351665 USD | 1.7 million USD |
2000Q1 | -238050 USD | 1.6 million USD |
1999Q4 | -100000 USD | 2.0 million USD |
1999Q3 | -300000 USD | 1.6 million USD |
1999Q2 | -400000 USD | 1.5 million USD |
1999Q1 | -400000 USD | 1.6 million USD |
1998Q4 | -300000 USD | 1.6 million USD |
1998Q3 | -500000 USD | 1.5 million USD |
1998Q2 | -500000 USD | 1.2 million USD |
1998Q1 | -500000 USD | 1.0 million USD |
1997Q4 | -400000 USD | 1.0 million USD |
RMTI Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -9.3 million USD | 80.8 million USD |
2022 | -20.6 million USD | 72.8 million USD |
2021 | -35.0 million USD | 61.9 million USD |
2020 | -31.9 million USD | 62.2 million USD |
2019 | -31.1 million USD | 61.3 million USD |
2018 | -32.1 million USD | 63.4 million USD |
2017 | -25.9 million USD | 57.3 million USD |
2016 | -19.8 million USD | 53.3 million USD |
2015 | -14.4 million USD | 55.4 million USD |
2014 | -21.3 million USD | 54.2 million USD |
2013 | -48.8 million USD | 52.4 million USD |
2012 | -54.0 million USD | 49.8 million USD |
2011 | -21.4 million USD | 49.0 million USD |
2010 | -2.7 million USD | 59.6 million USD |
2009 | -5.5 million USD | 54.7 million USD |
2008 | -7.9 million USD | 51.7 million USD |
2007 | -3.7 million USD | 43.0 million USD |
2006 | -4.6 million USD | 28.6 million USD |
2005 | 76808 USD | 27.7 million USD |
2004 | 211522 USD | 17.9 million USD |
2003 | 4853 USD | 15.0 million USD |
2002 | -980711 USD | 11.5 million USD |
2001 | -1.6 million USD | 9.0 million USD |
2000 | -1.0 million USD | 7.5 million USD |
1999 | -1.1 million USD | 6.7 million USD |
1998 | -1.9 million USD | 5.3 million USD |
1997 | -1.9 million USD | 3.3 million USD |
RMTI
Price: $1.46
52 week price:
Earnings Per Share: -0.37 USD
P/E Ratio: -1.36
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 309500
Ebitda: -4.9 millionMarket Capitalization: 47.4 million